Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hofer

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Journal of Viral Hepatitis|June 23, 2010
Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapyH Hofer, I Aydin, S Neumueller-Guber, et al.
Journal of Animal Physiology and Animal Nutrition|July 27, 2006
Digestion studies in captive Hippopotamidae: a group of large ungulates with an unusually low metabolic rateA Schwarm, S Ortmann, H Hofer, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Biological effects of 1alpha-hydroxy- and 1beta-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapyH Hofer, G m Ho, M Peterlik, et al.
Allergy|November 15, 2013
Differences in the intrinsic immunogenicity and allergenicity of Bet v 1 and related food allergens revealed by site-directed mutagenesisA Roulias, U Pichler, M Hauser, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 1, 1997
IRAG working group 2. CAM-based assays. Interagency Regulatory Alternatives GroupH Spielmann, M Liebsch, F Moldenhauer, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2015
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responsesM Mandorfer, K Kozbial, C Freissmuth, et al.
Alimentary Pharmacology & Therapeutics|May 29, 2013
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viralK Rutter, H Hofer, S Beinhardt, et al.
Hepatology (Baltimore, Md.)|October 27, 2001
Combination of interferon induction therapy and ribavirin in chronic hepatitis CP Ferenci, H Brunner, K Nachbaur, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 17, 2013
Allergen hybrids - next generation vaccines for Fagales pollen immunotherapyU Pichler, M Hauser, H Hofer, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis CA F Stättermayer, R Strassl, A Maieron, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Journal of Viral Hepatitis|June 23, 2010
Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapyH Hofer, I Aydin, S Neumueller-Guber, et al.
Journal of Animal Physiology and Animal Nutrition|July 27, 2006
Digestion studies in captive Hippopotamidae: a group of large ungulates with an unusually low metabolic rateA Schwarm, S Ortmann, H Hofer, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Biological effects of 1alpha-hydroxy- and 1beta-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapyH Hofer, G m Ho, M Peterlik, et al.
Allergy|November 15, 2013
Differences in the intrinsic immunogenicity and allergenicity of Bet v 1 and related food allergens revealed by site-directed mutagenesisA Roulias, U Pichler, M Hauser, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|January 1, 1997
IRAG working group 2. CAM-based assays. Interagency Regulatory Alternatives GroupH Spielmann, M Liebsch, F Moldenhauer, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2015
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responsesM Mandorfer, K Kozbial, C Freissmuth, et al.
Alimentary Pharmacology & Therapeutics|May 29, 2013
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viralK Rutter, H Hofer, S Beinhardt, et al.
Hepatology (Baltimore, Md.)|October 27, 2001
Combination of interferon induction therapy and ribavirin in chronic hepatitis CP Ferenci, H Brunner, K Nachbaur, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 17, 2013
Allergen hybrids - next generation vaccines for Fagales pollen immunotherapyU Pichler, M Hauser, H Hofer, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis CA F Stättermayer, R Strassl, A Maieron, et al.
Pageof 10